Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Immunovant Inc., 3 years.
Immunovant Inc.
Director
REGENXBIO Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunovant Inc. August 12, 202474.4%
-
REGENXBIO Inc. May 31, 202495.6%
-
Immunovant Inc. August 21, 202383.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | REGENXBIO Inc. | Grant or award | +9,807 | — | — |
| May 30, 2025 | REGENXBIO Inc. | Grant or award | +7,768 | — | — |
| Apr 1, 2025 | Immunovant Inc. | Grant or award | +16,188 | — | — |
| May 31, 2024 | REGENXBIO Inc. | Grant or award | +4,790 | — | — |
| Apr 2, 2024 | Immunovant Inc. | Grant or award | +11,255 | — | — |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −4,200 | $38.79 | $162,918 |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −3,478 | $39.81 | $138,459 |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −5,022 | $40.46 | $203,190 |
| Jun 2, 2023 | REGENXBIO Inc. | Grant or award | +3,486 | — | — |
| Apr 12, 2023 | Immunovant Inc. | Grant or award | +12,523 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.